10.6084/m9.figshare.c.3734302_D1.v1
Sardar Sindhu
Sardar
Sindhu
Nadeem Akhter
Nadeem
Akhter
Hossein Arefanian
Hossein
Arefanian
Areej Al-Roub
Areej
Al-Roub
Shamsha Ali
Shamsha
Ali
Ajit Wilson
Ajit
Wilson
Asma Al-Hubail
Asma
Al-Hubail
Shaima Al-Beloushi
Shaima
Al-Beloushi
Saad Al-Zanki
Saad
Al-Zanki
Rasheed Ahmad
Rasheed
Ahmad
Additional file 1: Figure S1. of Increased circulatory levels of fractalkine (CX3CL1) are associated with inflammatory chemokines and cytokines in individuals with type-2 diabetes
Springer Nature
2017
Fractalkine
CX3CL1
Chemokines
Cytokines
Inflammation
Obesity
Type-2 diabetes
2017-04-04 05:00:00
Figure
https://springernature.figshare.com/articles/figure/Additional_file_1_Figure_S1_of_Increased_circulatory_levels_of_fractalkine_CX3CL1_are_associated_with_inflammatory_chemokines_and_cytokines_in_individuals_with_type-2_diabetes/4817722
Plasma levels of fractalkine and selective inflammatory cytokines were measured in 23 type-2 diabetic (T2D) and 24 non-diabetic individuals using magnetic bead premixed 41-plex immune assays as described in Methods. The data show that in non-diabetic individuals, systemic fractalkine levels did not associate with (A) G-CSF (r = 0.31 P = 0.14); (B) IFN-α2 (r = 0.23 P = 0.28); (C) IL-17A (r = 0.10 P = 0.78); and (D) IL-6 (r = 0.18 P = 0.45). (TIF 716 kb)